wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26849316-6489B6BD-E36B-4A69-848F-87826B1E999E
Q26849316-6489B6BD-E36B-4A69-848F-87826B1E999E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26849316-6489B6BD-E36B-4A69-848F-87826B1E999E
Adaptive resistance to targeted therapies in cancer
P2860
Q26849316-6489B6BD-E36B-4A69-848F-87826B1E999E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26849316-6489B6BD-E36B-4A69-848F-87826B1E999E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
99c48c50670ba4d6b717207536dd682f9863b8b1
P2860
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study